Obermatt
See Similar Stocks →

Medtronic

NYQ:MDT · IE00BTN1Y115
Health Care Equipment & SuppliesXX-Large

360

70
EV / EBIT73
Price / Owner Earnings59
Owner Earnings Yield81
Dividend Yield84
Price/Sales22
EV / Gross Profit55
Price/Book42
Return on Capital35
Cash Return on Capital53
Return on Equity45
Profit margins70
Cash Conversion39
Owner Earnings Margin79
Sales growth68
Profit Growth98
Long-Term EPS Growth25
Owner Earnings Growth57
Reinvestment28
Price momentum56
Debt load53
Refinancing49
Debt Payback40
Liquidity65
Analyst ratings51
Opinion Changes50
Price Target Upside50
Market mood46
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Medtronic clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
TypePublic Company
ExchangeNYSE
Founded2014
Employees65,812
Websitemedtronic.com
ISINIE00BTN1Y115
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)D.J. US Health CareD.J. US Medical Equipment
Themes
Health DiagnosticsDiabetesCardiovascularPain ManagementArtificial IntelligenceBiomedical EngineeringUrologySurgeryNeurologyOrthopaedicsHealth CareMedical

Description

Medtronic plc operates as a healthcare technology company. The company is embracing its role as a healthcare technology leader and evolving the company’s business strategy in three key areas: Accelerate innovation-driven growth: The combination of…

Analysis

Bargain bin

Medtronic plc falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.

The price is fair. You pay 17.6× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 5% yearly growth; analysts expect 6%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
90
2023202420252026

All-time high

92

Mar 2026

All-time low

17

Jan 2023

Average rank

74

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
22
20
20
32
Price/Earnings
41
55
68
70
Price/Book
42
43
55
69
Dividend Yield
84
88
90
90
Value (overall)
46
65
69
81

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Medtronic with its peers
Medacta Group
SWX:MOVE
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Carl Zeiss Meditec
GER:AFX
50
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Medartis Holding
SWX:MED
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Ambu
CPH:AMBU B
77
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Elekta
STO:EKTA B
42
CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
LivaNova
NSQ:LIVN
76
CountryUK
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →